What's in Mahmoud Rashad Ahmed's pipeline?

Mahmoud Rashad Ahmed has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Mahmoud Rashad Ahmed's portfolio?

Top competitors by shared drug class: Samuel Lunenfeld Research Institute, Mount Sinai Hospital.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/mahmoud-rashad-ahmed.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Mahmoud Rashad Ahmed — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mahmoud Rashad Ahmed pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Continuous spinal anesthesia	Continuous spinal anesthesia	marketed	Local anesthetic (regional anesthesia technique)		Anesthesiology

Therapeutic area mix

Anesthesiology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Samuel Lunenfeld Research Institute, Mount Sinai Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Mahmoud Rashad Ahmed:

Cite this brief

Drug Landscape (2026). Mahmoud Rashad Ahmed — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/mahmoud-rashad-ahmed. Accessed 2026-05-18.